Alzheimer’s disease destroys the brain through a slow chain reaction of misfolded proteins, dying connections between nerve cells, and runaway inflammation. An estimated 7.1 million Americans are currently living with symptoms, and that number is projected to reach nearly 14 million by 2060. Understanding what actually happens inside the brain helps make sense of why the disease progresses the way it does.
Two Toxic Proteins Drive the Damage
The disease centers on two proteins that go wrong: beta-amyloid and tau. Both exist naturally in a healthy brain, but in Alzheimer’s, they become destructive.
Beta-amyloid is a fragment produced when the body breaks down a larger protein called amyloid precursor protein. Normally these fragments get cleared away. In Alzheimer’s, a particularly toxic form called beta-amyloid 42 accumulates and clumps together into sticky plaques that build up in the spaces between nerve cells. These plaques disrupt how neurons communicate with each other and trigger a cascade of further damage.
Inside the neurons, a second problem is unfolding. Tau is a protein that normally acts like scaffolding, holding together the tiny tube-shaped structures (microtubules) that transport nutrients and signals through the length of a nerve cell. Think of microtubules as the cell’s internal highway system, with tau as the support beams keeping the roads intact. In Alzheimer’s, tau becomes chemically altered, picking up three to four times more phosphate groups than normal. This hyperphosphorylated tau detaches from the microtubules and starts behaving toxically. It grabs onto healthy tau proteins and other structural supports, pulling them away from their jobs. The cell’s transport system collapses. The damaged tau then clumps into tangled fibers called neurofibrillary tangles, which choke the neuron from the inside. Roughly 40% of this toxic tau floats freely in the cell’s fluid rather than forming tangles, actively disrupting normal function even before tangles appear.
Where the Brain Breaks Down First
Alzheimer’s doesn’t attack the whole brain at once. It follows a predictable geographic pattern, starting in the areas most critical for memory. The earliest damage appears in the entorhinal cortex and hippocampus, two structures deep in the temporal lobe that are essential for forming new memories. This is why forgetting recent events is almost always the first noticeable symptom.
Brain imaging studies show that even before symptoms appear, the hippocampus is already shrinking faster than normal. As the disease progresses to mild stages, shrinkage spreads to the precuneus (involved in self-awareness and memory retrieval), the front of the brain, and the lower and side portions of the temporal lobes. By moderate stages, the most rapid tissue loss has shifted away from the hippocampus and into these broader cortical regions, which govern language, spatial awareness, and reasoning. This progression explains why someone in early Alzheimer’s mainly struggles with memory, while someone in later stages may lose the ability to recognize faces, follow conversations, or navigate familiar places.
How Nerve Cells Lose Contact
The loss of synapses, the connection points where nerve cells pass signals to one another, is the single strongest predictor of cognitive decline in Alzheimer’s. More than plaques or tangles, it’s the destruction of these connections that maps most directly onto how much thinking ability someone has lost.
Both amyloid plaques and tau tangles contribute to synapse destruction, but through different routes. Amyloid pathology disrupts how neurons regulate calcium, a mineral that cells use as a signaling tool. Normally, each synapse controls its own calcium levels independently. Under amyloid pathology, that compartmentalization breaks down, and calcium floods through the cell in an uncontrolled way. This destabilizes the tiny protrusions (dendritic spines) that form one half of each synaptic connection. Meanwhile, the death of neurons that produce acetylcholine, a chemical messenger critical for learning and memory, further reduces the brain’s ability to relay signals. The density of synaptic connections drops most sharply near amyloid plaques, creating dead zones of communication.
The Brain’s Immune System Turns Against Itself
The brain has its own resident immune cells called microglia, which normally patrol for debris and pathogens. In early Alzheimer’s, microglia detect amyloid plaques and activate to try clearing them away. But chronic exposure to the plaques pushes microglia into a permanently inflamed state. Instead of cleaning up, they begin releasing inflammatory molecules that damage surrounding neurons and synapses. Worse, this chronic activation actually inhibits their ability to clear amyloid, creating a vicious cycle where plaques accumulate faster while inflammation intensifies.
Microglia also recruit a second type of brain support cell, astrocytes, into the inflammatory response. Activated astrocytes swell, retract their normal supportive branches, and begin pumping out their own wave of inflammatory signals. These reactive astrocytes produce a molecule called C3 that binds to neurons and directly destroys their dendritic structure and synaptic connections. They also ramp up production of the very enzymes that generate more beta-amyloid, and they internalize and spread tau protein between cells, helping the disease propagate to new brain regions. The crosstalk between inflamed microglia and reactive astrocytes creates a self-reinforcing loop of damage that accelerates as the disease advances.
The Blood-Brain Barrier Breaks Down
The brain is normally protected by a tightly sealed layer of blood vessel cells called the blood-brain barrier, which controls what can enter brain tissue from the bloodstream. In Alzheimer’s, this barrier becomes leaky. The increased permeability allows toxic molecules, including beta-amyloid circulating in the blood, to pass into the brain more easily. At the same time, the brain’s ability to flush out waste products is impaired. This breakdown is considered a major event in the disease and accelerates neuronal death beyond what plaques and tangles alone would cause.
Genetics and the APOE-e4 Connection
The strongest genetic risk factor for the common, late-onset form of Alzheimer’s is a variant of the APOE gene called e4. Everyone carries two copies of the APOE gene, and each copy can be the e2, e3, or e4 version. The e3 variant is most common. Carrying one copy of e4 significantly increases risk; carrying two copies increases it even more. The e2 variant, by contrast, is protective.
The three versions of the APOE protein differ by just one or two amino acids, but those small changes dramatically alter how the protein behaves. ApoE4 seeds amyloid plaques earlier and in greater quantities than the other forms. It also affects lipid transport, receptor binding, and protein stability in ways that compound the damage. Researchers describe APOE4’s effect as a combination of gaining toxic properties and losing protective ones. Having the e4 variant doesn’t guarantee you’ll develop Alzheimer’s, and many people without it do. But it shifts the odds substantially.
How the Disease Progresses Over Time
Alzheimer’s typically unfolds over years to decades, though the pace varies enormously. People live an average of 3 to 11 years after diagnosis, though some live 20 years or more. The clinical progression generally moves through three broad stages.
In the mild stage, the primary problems are memory lapses for recently learned information, difficulty finding the right word, and getting lost even in familiar places. Misplacing belongings becomes common. Most people can still manage daily life with some adjustments, but the changes are noticeable to family and close friends.
During the moderate stage, confusion deepens. People lose track of the date, the season, or where they are. Judgment deteriorates, and help is needed with daily activities like choosing clothes or managing finances. Some people experience hallucinations. Agitation and restlessness often increase, particularly in the late afternoon and evening, a pattern sometimes called sundowning. Outbursts of frustration or aggression can occur as the person struggles to make sense of a world that feels increasingly unfamiliar.
In severe Alzheimer’s, communication breaks down almost entirely. A person may be unable to carry on a conversation or even speak coherently. Physical abilities decline as well: muscles stiffen, reflexes become abnormal, and eventually the ability to swallow, sit upright, or control bladder and bowel function is lost. At this stage, the disease has spread through much of the brain’s cortex, and full-time care is necessary.
How Alzheimer’s Is Detected
Diagnosis relies on a combination of cognitive testing, brain imaging, and increasingly, biological markers. MRI scans can reveal hippocampal shrinkage, which is one of the earliest visible signs. A specialized PET scan using a tracer called Pittsburgh Compound B can detect amyloid plaques in the living brain, confirming that the protein buildup characteristic of Alzheimer’s is present.
Cerebrospinal fluid analysis provides another window. In people with Alzheimer’s, levels of beta-amyloid 42 in spinal fluid drop by 30 to 50% compared to healthy individuals, because the protein is being trapped in brain plaques rather than flowing freely. At the same time, levels of tau and hyperphosphorylated tau in spinal fluid rise. This combination of low amyloid and high tau in cerebrospinal fluid has proven reliable across thousands of subjects studied at research centers worldwide, and these changes are detectable even in very early and mild stages of the disease.